Attached files

file filename
EX-99.1 - PRESS RELEASE - PixarBio Corppxrb_ex991.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): December 30, 2016

 

PixarBio Corporation

(Name of Small Business Issuer in its Charter)

 

Delaware

47-1945113

(State or Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

 

200 Boston Avenue, Suite 1875

Medford, MA 02155

(Address of principal executive offices)

 

(617) 803-8838

(Telephone Number of Principal Executive Offices)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 

ITEM 7.01 Regulation FD Disclosure.

 

PixarBio Corporation (the “Company”) issued a press release, dated January 5, 2017, in which the Company announced that it sold to Henry Sargent all of the membership interests in Buddhi Mat LLC, the Company’s wholly owned subsidiary.

 

ITEM 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

Description

99.1 

Press Release dated January 5, 2017– PixarBio Corporation (“PixarBio”) Entered into an Agreement with Henry Sargent, to Sell to Him all of the Membership Interests in PixarBio’s Wholly Owned Subsidiary Buddhi Mat LLC

 

 
2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 PixarBio Corporation
    

Dated: January 5, 2017

By:

/s/ Francis M. Reynolds

 

Name:

Francis M. Reynolds 
 Title:

Chief Executive Officer

 

 

 

3